Thymectacin

From Wikipedia, the free encyclopedia
  (Redirected from NB1011)
Jump to: navigation, search
Thymectacin
Skeletal formula of thymectacin
Space-filling model of the thymectacin molecule
Systematic (IUPAC) name
(2S)-methyl 2-((((2R,3S,5R)-5-(5-((E)-2-bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphorylamino)propanoate
Clinical data
Identifiers
232925-18-7 YesY
PubChem CID 6440764
ChemSpider 4945015 N
Chemical data
Formula C21H25BrN3O9P
574.3185 g/mol
 N (what is this?)  (verify)

Thymectacin (NB-1011, NB-101, N-[[5-[(E)-2-Bromovinyl]-2'-deoxyuridin-5'-O-yl]](phenoxy)phosphoryl]-L-alanine methyl ester) is an anticancer prodrug of brivudine monophosphate. It developed by New Biotics and it has entered in phase I clinical trials for colon cancer.[1]

References[edit]